Product
Ciclopirox Olamine
1 clinical trial
1 indication
Indication
Adverse Drug ReactionClinical trial
A Phase I, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy VolunteersStatus: Completed, Estimated PCD: 2024-04-08